Figure 8: (A) Western blots showing expression of apolipoprotein A-I, alpha-2-HS-glycoprotein, apolipoprotein A-IV and Serpin peptidase inhibitor, clade A (SERPINA1) among control and BC groups. Equal loading of the samples was evaluated by reprobing the membranes with ß-actin antibody. Lane1: Control 1; 2: Control 2; 3: Control 3; 4: BC1 5: BC2; 6: BC3. (B) Their percentage increment was calculated respect to control on the basis quantitative fold change of pixel density measured by UNSCAN- IT software.